A hospital-focused pharmaceutical company developing and commercializing therapies used in acute care settings, particularly for postoperative nausea and procedural sedation. Its key products have targeted unmet needs in anesthesia and surgery recovery, areas where hospital formulary adoption drives...
1 member of Congress has disclosed 1 trade in ACACIA PHARMACEUTICALS COMPANY INCORPORATED (ACAC), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-06-27 | MICHAEL T. MCCAUL | buy | $1K – $15K |